Shandong Sito Bio-Technology (300583.SZ) released the third quarter report of 2024, with the company's revenue for the first three quarters reaching 7...
According to the Zhì Tōng Finance APP, Shandong Sito Bio-Technology (300583.SZ) released the third quarter report of 2024. The company's revenue for the first three quarters decreased by 17.13% to 0.765 billion yuan. The net income attributable to shareholders of the listed company decreased by 75.94% to 14.7153 million yuan. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses decreased by 0.85% to 5.5072 million yuan. The basic earnings per share was 0.08 yuan.